The Neuromuscular Junction: A Shared Vulnerability in Aging and Disease
Kathryn R Moss1,2, Fereshteh B Darvishi3,2, Yomna Badawi4
1Department of Physical Medicine and Rehabilitation, University of Missouri School of Medicine, Columbia, Missouri 65211 kmoss@missouri.edu smitasaxena@missouri.edu.
Neuromuscular junction (NMJ) dysfunction drives aging and neuromuscular diseases. Targeting NMJ defects offers shared therapeutic strategies to preserve motor function and muscle strength.
Area of Science:
- Neuroscience
- Cell Biology
- Gerontology
Background:
- The neuromuscular junction (NMJ) is crucial for motor control.
- NMJ dysfunction is an early driver in aging and neuromuscular diseases like ALS and CMT.
- Aging impacts NMJ integrity, contributing to sarcopenia.
Purpose of the Study:
- To review mechanisms of NMJ impairment in aging and neuromuscular diseases.
- To explore emerging molecular drivers of NMJ dysfunction.
- To discuss therapeutic strategies targeting the NMJ.
Main Methods:
- Literature review integrating data from various neuromuscular conditions and aging studies.
- Analysis of presynaptic, postsynaptic, and perisynaptic Schwann cell defects.
- Exploration of omics approaches and congenital myasthenic syndromes.
Main Results:
- Shared and disease-specific mechanisms contribute to NMJ defects.
- Age-related NMJ changes are linked to sarcopenia.
- Novel molecular drivers and therapeutic targets are identified.
Conclusions:
- The NMJ is a critical, modifiable target for preserving motor function.
- Shared therapeutic strategies can stabilize NMJ function across diseases and aging.
- Translational research using organoid models and molecular profiling is key.
More Related Videos
08:41Dissection of Single Skeletal Muscle Fibers for Immunofluorescent and Morphometric Analyses of Whole-Mount Neuromuscular Junctions
Published on: August 14, 2021
11:03Characterization of Neuromuscular Junctions in Mice by Combined Confocal and Super-Resolution Microscopy
Published on: December 8, 2021
Related Concept Videos
The Neuromuscular Junction
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Neuromuscular Junction And Blockade
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Neural Regulation
